Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up?
- DOI
- 10.21037/tcr-2026-1245
- Published
- 2026-08
- Container
- Translational Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tcr-2026-1245,
title = {Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up?},
author = {Carlos Diego Holanda Lopes and Anna Spreafico and Daniel V. Araujo},
year = {2026},
journal = {Translational Cancer Research},
doi = {10.21037/tcr-2026-1245},
url = {https://doi.org/10.21037/tcr-2026-1245}
}RIS
TY - JOUR TI - Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up? AU - Carlos Diego Holanda Lopes AU - Anna Spreafico AU - Daniel V. Araujo PY - 2026 JO - Translational Cancer Research DO - 10.21037/tcr-2026-1245 UR - https://doi.org/10.21037/tcr-2026-1245 ER -
APA
Lopes, C. D. H., Spreafico, A., & Araujo, D. V. (2026). Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up?. Translational Cancer Research. https://doi.org/10.21037/tcr-2026-1245
Source records
- crossref · retrieved 2026-09-26T12:08:06.106Z